AstraZeneca Pharma
BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Pharmaceuticals
 |
Nine Months of AstraZeneca Pharma |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '06 | Sep '07 | Dec '07 | Sep '08 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 196.78 | 217.21 | 303.84 | 257.25 | 280.39 | |||||
| Other Income | 5.27 | 10.12 | 9.72 | 8.18 | 4.58 | |||||
| Total Income | 202.06 | 227.33 | 313.56 | 265.43 | 284.97 | |||||
| Total Expenses | 145.23 | 159.40 | 212.37 | 177.82 | 225.45 | |||||
| Operating Profit | 51.55 | 57.81 | 91.47 | 79.43 | 54.94 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 56.82 | 67.93 | 101.19 | 87.61 | 59.52 | |||||
| Interest | 0.03 | 0.02 | -- | 3.60 | 0.14 | |||||
| PBDT | 56.80 | 67.90 | 101.19 | 84.01 | 59.38 | |||||
| Depreciation | 4.26 | 4.28 | 5.84 | 4.90 | 4.51 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 52.54 | 63.62 | 95.35 | 79.11 | 54.87 | |||||
| Tax | 19.04 | 22.94 | 33.89 | 28.19 | 19.34 | |||||
| Net Profit | 33.50 | 40.68 | 61.46 | 50.92 | 35.53 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 66.99 | 16.27 | 24.58 | 20.37 | 14.21 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| Reserves | -- | -- | 154.31 | -- | -- | |||||
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore AstraZeneca connections | ||||||||||
| ||||||||||
